Results 211 to 220 of about 14,238 (246)
Some of the next articles are maybe not open access.

Congenital hyperinsulinism

Early Human Development, 2010
Congenital hyperinsulinism (CHI or HI) is a condition leading to recurrent hypoglycemia due to an inappropriate insulin secretion by the pancreatic islet beta cells. HI has two main characteristics: a high glucose requirement to correct hypoglycemia and a responsiveness of hypoglycemia to exogenous glucagon.
Jean-Baptiste, Arnoux   +15 more
openaire   +2 more sources

Hyperinsulinism and hyperammonaemia

Journal of Inherited Metabolic Disease, 1998
Hyperinsulinism and hyperammonaemia L . Al-Shamsan1, M. Al-Essa2, A. Al-Mutair2, A. Al-Ashwal2, N. Sakati2 and P. T . Ozand2,3* 1 Department of Pediatrics, King Fahad National Guard Hospital, Riyadh ; 2 Department of Pediatrics, King Faisal Specialist Hospital and Research Centre ; 3 Department of Biological and Medical Research, King Faisal Specialist
Nadia Sakati   +5 more
openaire   +2 more sources

Congenital Hyperinsulinism

NeoReviews, 2021
Hyperinsulinemic hypoglycemia (HH) is fairly common in neonates, particularly those born to diabetic mothers and those who are either large or small for gestational age. Immediate management of the disease focuses on achieving normoglycemia through frequent high-calorie feedings and/or intravenous glucose administration.
openaire   +2 more sources

Hyperinsulinism of the newborn

Seminars in Perinatology, 2000
Neonatal hyperinsulinism (HI) is a clinical syndrome of pancreatic beta-cell dysfunction characterized by failure to suppress insulin secretion in the presence of hypoglycemia. Although rare, it is the most common cause for persistent hypoglycemia in the newborn period.
openaire   +3 more sources

Neonatal Hyperinsulinism

Clinics in Perinatology, 1998
Hyperinsulinism is the most frequent cause of severe, persistent hypoglycemia in neonates and young infants. Timely diagnosis and aggressive treatment are necessary to prevent long-term neurologic sequelae. This article explores the latest advances in the understanding of the pathophysiology of this disorder at the molecular and cellular level.
V M, Schwitzgebel, S E, Gitelman
openaire   +2 more sources

Octreotide in Hyperinsulinism

Annals of Pharmacotherapy, 1997
In a limited number of case reports in infants, octreotide raised the blood glucose concentrations and decreased glucose requirements sufficiently to avoid pancreatectomy. This response occurs in the presence of frequent feedings and diazoxide therapy, and lasts from 1 month to greater than 5 years.
openaire   +3 more sources

The hyperinsulinism/hyperammonemia syndrome

Reviews in Endocrine and Metabolic Disorders, 2010
The hyperinsulinism/hyperammonemia (HI/HA) syndrome is the second most common form of congenital hyperinsulinism (HI). Children affected by this syndrome have both fasting and protein sensitive hypoglycemia combined with persistently elevated ammonia levels.
Charles A. Stanley, Andrew A. Palladino
openaire   +3 more sources

A Newborn with Congenital Hyperinsulinism

Fetal and Pediatric Pathology, 2019
Objective: Our aim was to describe the molecular alterations in the ABCC8 gene in a child with congenital hyperinsulinism (CHI). Methods: Genetic analysis of the ABCC8 gene of a newborn infant with congenial hyperinsulinism was obtained. Results: There were two mutations in the ABCC8 gene, c.4412delT, and c.3979G > A, indicating a compound heterozygous
Rong Ju, Peng Gou, Yufeng Xi, Yiting Du
openaire   +3 more sources

Genetics of Congenital Hyperinsulinism

Endocrine Pathology, 2004
Congenital hyperinsulinism (CHI) is a clinically and genetically heterogeneous entity and causes severe hypoglycemia in neonates and infants. The clinical heterogeneity is manifested by severity ranging from extremely severe, life-threatening disease to very mild clinical symptoms, which may even be difficult to identify.
Claudine Junien, Jean-Christophe Fournet
openaire   +3 more sources

Congenital hyperinsulinism

Current Opinion in Pediatrics, 2013
Congenital hyperinsulinism (CHI) is a multifaceted disease and continues to be the most common cause of persistent hypoglycemia in infants. The purpose of the review is to highlight important recent developments regarding CHI.Several recent studies have highlighted the advances in medical genetics, imaging techniques, histological variety, and surgical
openaire   +2 more sources

Home - About - Disclaimer - Privacy